BioGentech Corp. Confirms Successful Termination of Its Unauthorized Listing on Berlin-Bremen Stock Exchange
26. Mai 2004 09:00 ET
|
Cobalis Corp
IRVINE, Calif., May 26, 2004 (PRIMEZONE) -- BioGentech Corp. (OTCBB:BGTH), a publicly held Nevada corporation dedicated to developing and commercializing over-the-counter (OTC) products for the...
BioGentech Announces ClinDatrix as CRO for Phase III Trials
29. April 2004 16:30 ET
|
Cobalis Corp
IRVINE, Calif., April 29, 2004 (PRIMEZONE) -- BioGentech Corp. (OTCBB:BGTH), a pharmaceutical company specializing in over-the-counter anti-allergy medications, announced today that it has entered...
BioGentech's Trading Symbol Erroneously Receives "E"
07. April 2004 14:08 ET
|
Cobalis Corp
IRVINE, Calif., April 7, 2004 (PRIMEZONE) -- BioGentech Corp. (OTCBB:BGTH), a pharmaceutical company specializing in over-the-counter anti-allergy medications, today announced that the letter "E" it...
BioGentech Awarded Australian Patent Covering the Use of Cyanocobalamin (Vitamin B12) for the Treatment of Seasonal Allergies
01. April 2004 18:52 ET
|
Cobalis Corp
IRVINE, Calif., April 1, 2004 (PRIMEZONE) -- BioGentech Corp. (OTCBB:BGTH), a pharmaceutical company specializing in over-the-counter anti-allergy medications, announced today that it has recently...
BioGentech Finalizes Outsourcing Partnerships for Prehistin Phase III Clinical Trials
31. März 2004 16:54 ET
|
Cobalis Corp
IRVINE, Calif., March 31, 2004 (PRIMEZONE) -- BioGentech Corp. (OTCBB:BGTH), a pharmaceutical company specializing in over-the-counter anti-allergy medications, announced today the finalization of...
BioGentech Receives FDA Approval to Begin Phase III Clinical Trials
26. März 2004 17:20 ET
|
Cobalis Corp
IRVINE, Calif., March 26, 2004 (PRIMEZONE) -- BioGentech Corp. (OTCBB:BGTH), a pharmaceutical company specializing in over-the-counter anti-allergy medications, announced today the Division of...
BioGentech Appoints Chairman and Additional Board Member
26. März 2004 08:30 ET
|
Cobalis Corp
IRVINE, Calif., March 26, 2004 (PRIMEZONE) -- BioGentech Corp. (OTCBB:BGTH), a pharmaceutical company specializing in over-the-counter anti-allergic medications, announced today that its Board of...